The plant, expected to create about 120 new jobs, will manufacture elastomer components used in injectable drug delivery systems.
Construction will start by the end of 2016, with production set to begin in early 2018.
Datwyler hopes the new plant will help strengthen its position in the global drug market.
More articles on supply chain:
Clinicians should take stock of patients, not shelves: 3 thoughts on supply chain’s role in patient care
Coastal hospitals prepare supplies for Hurricane Matthew
5 drugs awaiting FDA review in October
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
